Ipamorelin is the best entry-point GH peptide — the cleanest GHRP available, with no meaningful cortisol or prolactin elevation. Stack it with CJC-1295 for the strongest GH output: CJC-1295 increases pulse amplitude while ipamorelin increases pulse frequency, producing synergistic GH release. MK-677 is the best oral option, with clinical data showing 50–89% increases in GH and 52–79% increases in IGF-1 over 7 days — but blood sugar elevation is a real tradeoff to monitor.
| # | Compound | Best For | Form | Availability | Details |
|---|---|---|---|---|---|
| 1 | IpamorelinBest Overall | Cleanest GH pulse, minimal side effects, best first GHRP | Injectable | TelehealthResearch | Full guide → |
| 2 | CJC-1295Best Stacked | Extends GH pulse duration; pairs with ipamorelin for max output | Injectable | TelehealthResearch | Full guide → |
| 3 | MK-677Best Oral Option | No injections; strong GH/IGF-1 data; recovery and sleep | Oral (capsule) | Research | Full guide → |
How GH Peptides Build Muscle — The Mechanism
Growth hormone peptides don't directly build muscle. What they do is stimulate your pituitary gland to release more of your own growth hormone — which then triggers the liver to produce IGF-1 (insulin-like growth factor 1). IGF-1 is the primary downstream driver of muscle protein synthesis: it activates mTOR and PI3K signaling pathways, promotes myoblast differentiation into mature muscle fibers, and recruits satellite cells for tissue repair after training.
This is mechanistically different from exogenous GH injections, which bypass your pituitary entirely and suppress the natural GH axis over time. GH peptides work with your body's existing feedback systems — the pituitary still regulates output, GH pulsatility is preserved, and there is no axis suppression. For most people, this makes GH peptides the preferred approach over exogenous GH for sustainable, long-term use.
The GH axis has two natural control points that peptides target:
- GHRH (growth hormone-releasing hormone) — produced in the hypothalamus, it signals the pituitary to release GH and controls the size (amplitude) of each GH pulse. CJC-1295 mimics this signal.
- Ghrelin / GHS-R — the ghrelin receptor in the pituitary controls the frequency of GH pulses and the sensitivity of the gland. Ipamorelin and MK-677 both act on this receptor.
Combining a GHRH analogue (CJC-1295) with a ghrelin mimetic (ipamorelin) hits both control points simultaneously — producing substantially more total GH output than either compound alone. This is why the CJC-1295 + ipamorelin stack is the most prescribed GH peptide combination in clinical practice.
Ipamorelin is a pentapeptide GHRP that selectively stimulates GH release through the ghrelin receptor in the pituitary. What separates it from older GHRPs (GHRP-2, GHRP-6) is its selectivity: ipamorelin produces a clean GH pulse without meaningfully elevating cortisol, prolactin, ACTH, or stimulating significant appetite. It is consistently described as the first GHRP recommended for new users due to this favorable tolerability profile.
What it does for muscle
Ipamorelin produces natural-style pulsatile GH release that mimics the body's nocturnal GH output. Users consistently report three early effects: improved sleep depth and quality (within 1–2 weeks), faster post-training recovery, and gradual body recomposition over 8–12 weeks. Over longer protocols (16–24 weeks), lean mass accumulation and fat reduction become clearly visible when combined with resistance training.
Selectivity vs. other GHRPs
GHRP-2 and GHRP-6 also stimulate GH release effectively, but both produce notable cortisol elevation, prolactin increases, and strong appetite stimulation. Cortisol is catabolic to muscle — its chronic elevation actively counteracts the anabolic effects you're trying to create. Ipamorelin's clean profile means the full GH benefit is realized without hormonal interference, making it the correct default choice over older GHRPs.
Timing matters
Ipamorelin is most effective injected on an empty stomach, ideally 30–60 minutes before bed. This aligns the drug-induced GH pulse with the body's natural deep-sleep GH release window, producing an amplified overnight pulse. Daytime injections before training are a secondary option for recovery enhancement.
CJC-1295 is a GHRH analogue with a Drug Affinity Complex (DAC) modification that binds it to albumin in the bloodstream, extending its half-life from minutes to approximately 6–8 days. This means the pituitary is continuously primed to release GH, so when ipamorelin triggers a pulse, the response is substantially amplified. Clinical research in healthy adults confirms CJC-1295 effectively increases both GH secretion and IGF-1 production while preserving the natural pulsatility of the GH axis.
Why it stacks so well with ipamorelin
CJC-1295 and ipamorelin target entirely different receptors and mechanisms — they don't compete, they complement. CJC-1295 acts on GRF receptors to increase the amplitude (size) of each GH pulse. Ipamorelin acts on the ghrelin receptor to increase the frequency (number) of pulses. Together they produce a multiplicative increase in total GH output. This is the same principle as combining a GHRH + GHRP in research settings, but with a long-acting GHRH analogue that reduces injection frequency.
What the research shows
Studies confirm CJC-1295 "increases GH secretion and IGF-1 production with preserved pulsatility" in healthy adults. Users report consistent improvements in body composition — reduced body fat, improved lean mass, better recovery, and enhanced sleep quality — over 2–3 months of use. Due to CJC-1295's long half-life, only 1–2 injections per week are required, compared to daily injections for pure GHRP protocols.
MK-677 (ibutamoren) is an orally active ghrelin mimetic that stimulates GH and IGF-1 through the same GHS-R receptor as ipamorelin — but taken as a daily capsule rather than an injection. It is the only compound on this list with a 24-hour half-life, meaning a single dose maintains elevated GH/IGF-1 levels around the clock. This makes it appealing for those who want the benefits of GH peptide therapy without needles.
What the clinical trials show
The evidence base for MK-677 is unusually strong for a research compound. A 7-day clinical study showed MK-677 at standard doses increased GH secretion by 50–89% and elevated IGF-1 by 52–79%. An 8-week controlled trial at 25mg/day demonstrated a gain of approximately 1.1kg of fat-free mass alongside an increase in basal metabolic rate — without a corresponding change in fat mass (suggesting the body composition shift was lean mass, not fat). MK-677 also "completely reversed diet-induced negative nitrogen balance" during caloric restriction in a separate study — a notable finding for anyone using it during a cut or recomposition phase.
Sleep as a muscle recovery driver
A 7-day sleep study showed MK-677 significantly increased REM sleep duration in both young and older adults. This is relevant for muscle growth: the majority of GH release and tissue repair occurs during slow-wave and REM sleep. Improving sleep quality and duration is one of the most underappreciated drivers of muscle recovery and anabolism.
The blood sugar tradeoff
MK-677's primary concern is blood glucose elevation. Ghrelin receptor agonism increases appetite and can impair insulin sensitivity over time — making it a poor choice for people with pre-diabetes, insulin resistance, or metabolic syndrome. This is the primary reason many physicians prefer the ipamorelin + CJC-1295 combination for long-term protocols: equivalent or superior GH output without the glucose liability. If you use MK-677, fasting blood glucose monitoring every 4–6 weeks is strongly recommended.
How to Stack These Compounds
The three compounds on this page can be used individually or in combination. Here are the most practical stacking approaches:
Side-by-Side Comparison
| Factor | Ipamorelin | CJC-1295 | MK-677 |
|---|---|---|---|
| Mechanism | Ghrelin receptor agonist (GHRP) | GHRH analogue | Oral ghrelin mimetic |
| GH axis target | Pulse frequency | Pulse amplitude | Pulse frequency + sustained |
| Form | Injectable | Injectable | Oral capsule |
| Injection frequency | 1–3×/day | 1–2×/week | None |
| Half-life | ~2 hours | ~6–8 days (DAC) | ~24 hours |
| Cortisol elevation | None | None | Minimal |
| Appetite stimulation | Minimal | None | Significant |
| Blood glucose risk | None | None | Moderate — monitor |
| Telehealth available | Yes | Yes | Research only |
| Best use case | First GHRP, daily stack | Long-acting stack partner | Oral alternative, recovery/sleep |
What to Expect — A Realistic Timeline
- Week 1–2: Improved sleep depth is usually the first noticeable effect. Recovery between training sessions begins to improve. Some users report vivid dreams — a sign of increased REM duration.
- Week 4–8: Body composition begins shifting. Subtle reduction in body fat, particularly midsection. Muscle fullness improves. Strength increases reflect better recovery rather than direct anabolic signaling at this stage.
- Week 8–16: Lean mass accumulation becomes visible. This is where resistance training investment pays off — IGF-1 elevations are providing the anabolic signal; the muscle response depends on the training stimulus you're providing.
- Week 16–24: Full body recomposition effects. Consistent users typically report a leaner, more muscular physique compared to baseline with the same training program they were running before peptides.
These compounds are not steroids — the timeline is longer and the magnitude is more modest. The value is in the quality of the gain: lean, dry muscle tissue with improved recovery and sleep, without hormonal axis suppression.
Where to Get Muscle Growth Peptides
Ipamorelin and CJC-1295 are available as physician-prescribed compounds through telehealth clinics — this is the recommended route for supervised dosing, lab monitoring, and access to the combined formulation. MK-677 is research-grade only and available without a prescription from research vendors.
- Defy Medical — Prescribes ipamorelin and CJC-1295 individually and as a combined formulation. ~$200/mo. Read review →
- Marek Health — $166/mo. Read review →
- NextGenPeps — Ipamorelin, CJC-1295, and MK-677 available as research compounds. Code 3LUIZH10 for a discount.
Frequently Asked Questions
Not sure which stack is right for you?
Use our goal picker — it shows the best compounds for your specific goal with exact pricing from telehealth clinics and research vendors.
Find My Peptide →